Stephen J. Gray

3.4k total citations
44 papers, 2.4k citations indexed

About

Stephen J. Gray is a scholar working on Microbiology, Epidemiology and Molecular Biology. According to data from OpenAlex, Stephen J. Gray has authored 44 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Microbiology, 29 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Stephen J. Gray's work include Bacterial Infections and Vaccines (32 papers), Pneumonia and Respiratory Infections (24 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Stephen J. Gray is often cited by papers focused on Bacterial Infections and Vaccines (32 papers), Pneumonia and Respiratory Infections (24 papers) and Pneumocystis jirovecii pneumonia detection and treatment (5 papers). Stephen J. Gray collaborates with scholars based in United Kingdom, Italy and France. Stephen J. Gray's co-authors include Edward B. Kaczmarski, B S Jenkins, Ray Borrow, Martin Maiden, Malcolm Guiver, Jeff Browne, Cormac Breen, Joan C. Egrie, Iain C. Macdougall and Rachel Urwin and has published in prestigious journals such as PLoS ONE, Journal of Bacteriology and Kidney International.

In The Last Decade

Stephen J. Gray

43 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen J. Gray United Kingdom 28 1.4k 1.3k 612 289 281 44 2.4k
Robert W. Novak United States 21 260 0.2× 404 0.3× 158 0.3× 341 1.2× 61 0.2× 58 1.5k
H Khayam-Bashi United States 17 167 0.1× 273 0.2× 67 0.1× 115 0.4× 52 0.2× 42 1.0k
Marina Ulanova Canada 23 650 0.5× 747 0.6× 54 0.1× 402 1.4× 21 0.1× 90 1.8k
Shalini Shenoy India 26 50 0.0× 293 0.2× 615 1.0× 229 0.8× 44 0.2× 134 2.3k
W. Opferkuch Germany 26 84 0.1× 263 0.2× 156 0.3× 396 1.4× 74 0.3× 119 2.1k
Patrick J. Scannon United States 13 269 0.2× 503 0.4× 66 0.1× 347 1.2× 37 0.1× 24 1.5k
David J. Schmeling United States 22 226 0.2× 267 0.2× 50 0.1× 370 1.3× 50 0.2× 35 1.8k
Rafael L. Jurado United States 10 79 0.1× 252 0.2× 179 0.3× 70 0.2× 34 0.1× 15 787
Håkan Odeberg Sweden 15 339 0.2× 128 0.1× 87 0.1× 365 1.3× 17 0.1× 34 1.3k
Carlo Bonfanti Italy 24 72 0.0× 430 0.3× 502 0.8× 183 0.6× 6 0.0× 90 1.8k

Countries citing papers authored by Stephen J. Gray

Since Specialization
Citations

This map shows the geographic impact of Stephen J. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Gray more than expected).

Fields of papers citing papers by Stephen J. Gray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Gray. The network helps show where Stephen J. Gray may publish in the future.

Co-authorship network of co-authors of Stephen J. Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Gray. A scholar is included among the top collaborators of Stephen J. Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Gray. Stephen J. Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parikh, Sydel R., Helen Campbell, Stephen J. Gray, et al.. (2018). Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010–2015. Vaccine. 36(26). 3876–3881. 32 indexed citations
2.
Knol, Mirjam J., Susan Hahné, Jay Lucidarme, et al.. (2017). Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. The Lancet Public Health. 2(10). e473–e482. 61 indexed citations
4.
Hill, Dorothea M. C., Jay Lucidarme, Stephen J. Gray, et al.. (2015). Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study. The Lancet Infectious Diseases. 15(12). 1420–1428. 49 indexed citations
5.
Mackay, J. H. & Stephen J. Gray. (2013). Principles and Practice of Anesthesia for Thoracic Surgery. British Journal of Anaesthesia. 110(5). 857–858. 15 indexed citations
6.
Ladhani, Shamez, Jay Lucidarme, Lynne S. Newbold, et al.. (2012). Invasive Meningococcal Capsular Group Y Disease, England and Wales, 2007–2009. Emerging infectious diseases. 18(1). 63–70. 59 indexed citations
7.
Ladhani, Shamez, Jessica Flood, Mary Ramsay, et al.. (2012). Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccines. Vaccine. 30(24). 3710–3716. 102 indexed citations
8.
Jenkins, Paul R., A. James Wilson, Daniel P. G. Emmerson, et al.. (2008). Design, synthesis and biological evaluation of new tryptamine and tetrahydro-β-carboline-based selective inhibitors of CDK4. Bioorganic & Medicinal Chemistry. 16(16). 7728–7739. 55 indexed citations
9.
Bille, Emmanuelle, Roisin Ure, Stephen J. Gray, et al.. (2008). Association of a Bacteriophage with Meningococcal Disease in Young Adults. PLoS ONE. 3(12). e3885–e3885. 51 indexed citations
10.
Findlow, Helen, Ulrich Vogel, Judith E. Mueller, et al.. (2007). Three Cases of Invasive Meningococcal Disease Caused by a Capsule Null Locus Strain Circulating among Healthy Carriers in Burkina Faso. The Journal of Infectious Diseases. 195(7). 1071–1077. 45 indexed citations
11.
Jadoul, Michel, et al.. (2004). Darbepoetin alfa administered once monthly maintains haemoglobin levels in stable dialysis patients. Nephrology Dialysis Transplantation. 19(4). 898–903. 65 indexed citations
12.
Bashir, Haitham El, Pietro G. Coen, Elizabeth Haworth, et al.. (2004). Meningococcal W135 carriage; enhanced surveillance amongst east London Muslim pilgrims and their household contacts before and after attending the 2002 Hajj. Travel Medicine and Infectious Disease. 2(1). 13–15. 8 indexed citations
13.
Vanrenterghem, Yves, Peter Bárány, Johannes F.E. Mann, et al.. (2002). Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients. Kidney International. 62(6). 2167–2175. 129 indexed citations
14.
Kaczmarski, Ed, Malcolm Guiver, Ray Borrow, et al.. (2002). Non-culture based characterisation of Neisseria meningitidis to guide public health interventions and vaccine development. Journal of Infection. 44(2). 109–109. 2 indexed citations
15.
Guiver, Malcolm, Ray Borrow, John C. Marsh, et al.. (2000). Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunology & Medical Microbiology. 28(2). 173–179. 120 indexed citations
16.
Borrow, Ray, et al.. (2000). Prevalence of de-O-acetylated serogroup C meningococci before the introduction of meningococcal serogroup C conjugate vaccines in the United Kingdom. FEMS Immunology & Medical Microbiology. 28(3). 189–191. 24 indexed citations
17.
Barnes, R.A., Stephen J. Gray, Andrew Carr, et al.. (2000). Measurement of Serum Antigen Concentration by Ultrasound-Enhanced Immunoassay and Correlation with Clinical Outcome in Meningococcal Disease. European Journal of Clinical Microbiology & Infectious Diseases. 19(4). 260–266. 10 indexed citations
18.
Macdougall, Iain C., Stephen J. Gray, Cormac Breen, et al.. (1999). Pharmacokinetics of Novel Erythropoiesis Stimulating Protein Compared with Epoetin Alfa in Dialysis Patients. Journal of the American Society of Nephrology. 10(11). 2392–2395. 314 indexed citations
19.
Gray, Stephen J. & Stan Heptinstall. (1991). Interactions between prostaglandin E2 and inhibitors of platelet aggregation which act through cyclic AMP. European Journal of Pharmacology. 194(1). 63–70. 27 indexed citations
20.
Gray, Stephen J. & Stan Heptinstall. (1985). The effects of PGE2 and CL 115,347, an antihypertensive PGE2 analogue, on human blood platelet behaviour and vascular contractility. European Journal of Pharmacology. 114(2). 129–137. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026